Kev Dhaliwal, MBChB (Hons), BSc (Hons), PhD, FRCP is a Senior Clinical Lecturer in Pulmonary Molecular Imaging at the MRC Centre for Inflammation Research in the Queen’s Medical Research Institute (QMRI) and Consultant Physician in Respiratory Medicine. After graduating from Edinburgh Medical School, he completed general professional training in London before returning to Edinburgh to undertake a MRC Clinical Training Fellowship. He combined clinical and academic training as a clinical lecturer and developed a research theme in pulmonary optical molecular imaging. Kev is chief investigator on 5 first-in-man trials ranging from the intensive care unit to lung cancer evaluating optical imaging approaches. He leads the interdisciplinary hub of scientists in the QMRI as part of the Proteus Project (www.proteus.ac.uk), the UK’s largest healthcare bio-photonics project which is an Engineering Physical Sciences Research Council Interdisciplinary Research Collaboration developing next-generation translational technologies for in situ pulmonary molecular imaging and sensing in pulmonary critical care. He is the Medical School lead for the OPTIMA EPSRC and MRC Centre for Doctoral Training in Optical Medical Imaging (www.optima-cdt.ac.uk) which embeds entrepreneurship within the training programme. In 2014, he co-founded Edinburgh Molecular Imaging (EMI) (www.edinimage.com) which is developing optical molecular imaging approaches for colorectal cancer detection and intraoperative surgical guidance. As a clinical founder director for EMI, he is establishing global clinical trials of optical imaging in the US, Europe and Far East and developing networks to expedite clinical adoption.
Multiplexed optical molecular sensing and imaging in the lungs
